About JHS Svendgaard Laboratories Limited

JHS Svendgaard Laboratories Limited is a leading Indian contract manufacturer of oral care products, offering integrated capabilities across toothbrushes, toothpastes, mouthwashes, whitening gels, denture tablets, and talcum powders. The Company operates primarily under a private-label model, manufacturing for established consumer brands such as Dabur, Patanjali, Amway, Reliance Consumer Products, and Jyothy Labs, serving both domestic and international clients.

The Company’s state-of-the-art manufacturing facilities are located at Kala-Amb, Himachal Pradesh, featuring mechanical and chemical manufacturing under one roof, supported by an in-house R&D centre, quality control laboratory, and global-standard production systems. JHS holds certifications including ISO 9001, ISO 13485, FDA, GMP, and AAYUSH, reflecting compliance with international quality benchmarks.

Founded in the early 2000s, JHS achieved a major milestone when its shares were listed on BSE and NSE on October 21, 2006, at an issue price of Rs 58 per equity share. Today, the Company is recognised as India’s largest integrated oral care manufacturer, offering a one-stop manufacturing solution for brands in India and abroad.

JHS continues to expand its global presence—entering the United States through Orazen Inc. and re-entering Middle Eastern markets via Classico Brands—while maintaining strong growth in India. As on March 31, 2025, the Company had 263 permanent employees, reflecting its operational depth and scale.

JHS Svendgaard Laboratories Limited Products and Services

• Contract manufacturing and private-label solutions across toothbrushes, toothpastes, mouthwashes, whitening gels, denture tablets, and talcum powders. 
• End-to-end integrated manufacturing supported by in-house R&D, quality assurance, and advanced equipment from global suppliers. 
• Certified under ISO 9001, ISO 13485, FDA, GMP, and AAYUSH, ensuring compliance with international quality standards. 

Geographies

• Strong presence in the domestic Indian market. 
• Expanding international footprint through exports to the United States and Middle Eastern markets via new business entries and partnerships. 

Subsidiaries

• As on March 31, 2025, the Company had 1 wholly owned subsidiary. 

JHS Svendgaard Laboratories Limited Key Milestones

• Listed on BSE and NSE on October 21, 2006, at an issue price of Rs 58 per share. 
• Emerged as India’s largest integrated oral care manufacturer, operating fully integrated facilities at Kala-Amb, Himachal Pradesh. 

JHS Svendgaard Laboratories Limited Business Segments

Revenue contribution by product verticals (FY 2024–25):

• Toothbrushes – 60.7% 
• Toothpastes – 30.2% 
• Talcum – 5.1% 
• Others – 4.0% 

JHS Svendgaard Laboratories Limited Key Management

• Mr. Rajagopal Chakravarthi Venkateish – Chairman, Non-Executive Director 
• Mr. Nikhil Nanda – Managing Director 
• Mr. Paramvir Singh – Chief Executive Officer & Executive Director 
• Mr. Ashish Goel – Chief Financial Officer 
• Mrs. Komal Jha – Company Secretary & Compliance Officer 

Latest Updates on JHS Svendgaard Laboratories Limited

• Market expansion: Entered the United States through Orazen Inc. and achieved sales in Dubai via Classico Brands, reinforcing its global expansion alongside strong domestic growth. 
• Capacity scale-up: Increased talcum output capacity from 3,000 units to 10,000 units during FY 2024–25, with further expansion planned in the second half of 2025. 
• Capital raise: On August 3, 2024, the Company issued 72,07,204 equity shares and 36,03,602 fully convertible warrants. As on March 31, 2025, the warrants remained outstanding (convertible by February 3, 2026). Of the Rs 2,000 lakh (shares) and Rs 250 lakh (warrants) raised, Rs 71.29 lakh was deployed for the Jammu & Kashmir project, Rs 749.50 lakh for general corporate purposes, and Rs 1,429.21 lakh was placed in fixed deposits pending utilisation. On May 17, 2025, the Board approved updated fund utilisation, including capex for manufacturing equipment and strategic infusion into a group entity. 
• Corporate actions: JHS Svendgaard Retail Ventures Ltd (the resulting company from a Scheme of Arrangement) was listed on BSE and NSE on June 26, 2024. 
• Leadership updates: Appointment of Mrs. Upma Chawdhry as Non-Executive Independent Director with effect from August 14, 2024, and elevation of Mr. Paramvir Singh as Executive Director with effect from November 13, 2024 (shareholder approval on February 10, 2025). 
• Performance highlight: Reported 30% year-on-year growth in FY 2024–25, driven by strong domestic and international performance, with continued investments in R&D and manufacturing infrastructure.